Loading...
CALLEX MEDICAMENTOS S. DE RL DE CV — Cyclophosphamide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #15 buyer for Cyclophosphamide · $107.3K import value · 23 shipments · MEXICO · DGFT Verified
CALLEX MEDICAMENTOS S. DE RL DE CV is the #15 importer of Cyclophosphamide from India with $107.3K in import value and 23 verified shipments. CALLEX MEDICAMENTOS S. DE RL DE CV holds a 0.5% market share in Cyclophosphamide imports based in MEXICO. The company sources from 1 verified supplier across 3 formulations shipped to 1 country.
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLS PHARMA LIMITED | $107.3K | 23 | 100.0% |
CALLEX MEDICAMENTOS S. DE RL DE CV sources Cyclophosphamide from 1 verified Indian supplier based on 23 customs records. The primary supplier is GLS PHARMA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | AUROMEDICS PHARMA, LLC,., | UNITED STATES | $100.0K | 2 | $50.0K |
| 11 | XXNEAXXEU XXMITXX | UNITED STATES | $100.0K | 2 | $50.0K |
| 15 | CALLEX MEDICAMENTOS S. DE RL DE CV ★ | MEXICO | $88.1K | 19 | $4.6K |
CALLEX MEDICAMENTOS S. DE RL DE CV ranks #15 among 518 Cyclophosphamide importers from India. Average shipment value of $4.6K compared to the market average of $7.2K. The closest competitors by value are AUROMEDICS PHARMA, LLC,., and XXNEAXXEU XXMITXX.
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $107.3K | 23 | 100.0% |
CALLEX MEDICAMENTOS S. DE RL DE CV imports Cyclophosphamide to 1 country. The primary destination is MEXICO receiving 100.0% of shipments worth $107.3K.
| Formulation | Value | Shipments |
|---|---|---|
| PONFECYC 200MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 200MG/VIAL)VLS | $52.4K | 11 |
| PONFECYC 500MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 500MG/VIAL)VLS | $35.7K | 8 |
| PONFECYC 500MG INJECTION CYCLOPHOSPHAMIDE FOR INJECTION 500MG/VIAL | $19.2K | 4 |
CALLEX MEDICAMENTOS S. DE RL DE CV imports 3 distinct Cyclophosphamide formulations from India. The top formulation is PONFECYC 200MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 200 with 11 shipments worth $52.4K.
What CALLEX MEDICAMENTOS S. DE RL DE CV and other importers must comply with to import Cyclophosphamide from India
Federal Commission for the Protection against Sanitary Risk (COFEPRIS)
Generic drug registration under Mexican health law. Requires bioequivalence study and GMP compliance. NOM standards apply.
Typical timeline: 12–18 months
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
India exported $3.7M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. CALLEX MEDICAMENTOS S. DE RL DE CV imports $107.3K of this total, accounting for 0.5% of India's Cyclophosphamide exports with 23 shipments from MEXICO. This is verified from 23 customs shipment records covering 3 distinct formulations.
CALLEX MEDICAMENTOS S. DE RL DE CV's average Cyclophosphamide order value is $4.7K per consignment, based on 23 shipments totaling $107.3K. CALLEX MEDICAMENTOS S. DE RL DE CV is based in MEXICO and ranks #15 among all Cyclophosphamide importers from India by value. The company sources from 1 verified supplier in India.
CALLEX MEDICAMENTOS S. DE RL DE CV sources Cyclophosphamide from 1 verified Indian supplier: GLS PHARMA LIMITED ($107.3K, 100.0%). This is based on 23 customs records.
CALLEX MEDICAMENTOS S. DE RL DE CV ranks #15 among 518 Cyclophosphamide importers from India with a 0.5% market share. The top 3 importers are EUGIA US LLC ($550.0K), CIPLA USA INC UPS SUPPLY CHAIN SOLU ($500.0K), J. KNIPPER & COMPANY ($467.5K). CALLEX MEDICAMENTOS S. DE RL DE CV processed 23 shipments from MEXICO.
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for CALLEX MEDICAMENTOS S. DE RL DE CV's Cyclophosphamide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CALLEX MEDICAMENTOS S. DE RL DE CV
Company Profile
Multiple products · $0 total trade · Multiple categories
Sanitary Import Permit from COFEPRIS; import licence via Mexican customs (SAT)
Spanish language labeling mandatory; Mexican Official Norms (NOM) compliance
Note: Mexico requires GMP compliance per NOM-059. COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available COFEPRIS guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with COFEPRIS or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for CALLEX MEDICAMENTOS S. DE RL DE CV.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current order-level data, contact TransData Nexus.